What’s new with biomarker-driven clinical strategy in sepsis and circulatory failure?

被引：0
|
作者：
Armand Mekontso Dessap
Lorraine B. Ware
Lila Bouadma
机构：
[1] Hôpitaux Universitaires Henri Mondor,Assistance Publique
[2] Université Paris Est Créteil,Hôpitaux de Paris, DHU A
[3] Vanderbilt University School of Medicine,TVB, Service de Réanimation Médicale
[4] Hôpitaux Universitaires Paris Nord-Val de Seine,Faculté de Médecine de Créteil, IMRB, Groupe de Recherche Clinique CARMAS
[5] Paris,Division of Allergy, Pulmonary, and Critical Care Medicine, T1218 Medical Center North Department of Medicine
[6] INSERM,Assistance Publique
[7] IAME Team 5 DeScID : Decision Science in Infectious Diseases,Hôpitaux de Paris, Réanimation Médicale et des Maladies Infectieuses, Hôpital Bichat
[8] Control and Care,Claude
[9] UMR 1137,Bernard
[10] Sorbonne Paris Cité,University Paris Diderot
来源：
Intensive Care Medicine | 2016年 / 42卷
关键词：
Intensive Care Unit Patient; Circulatory Failure; Lactate Clearance; Central Venous Oxygen Saturation; Pancreatic Stone Protein;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：418 / 421
页数：3
相关论文
共 50 条
  • [1] What's new with biomarker-driven clinical strategy in sepsis and circulatory failure?
    Dessap, Armand Mekontso
    Ware, Lorraine B.
    Bouadma, Lila
    INTENSIVE CARE MEDICINE, 2016, 42 (03) : 418 - 421
  • [2] Efficiency of Biomarker-Driven Clinical Trial Designs
    Freidlin, Boris
    Korn, Edward L.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (12)
  • [3] BIOMARKER-DRIVEN TARGETED ORAL TREATMENT STRATEGY FOR BLADDER CANCER
    Schimmelpfennig, Daley
    Kemper, Michael W.
    Lokeshwar, Soum D.
    Jordan, Andre
    Lokeshwar, Vinata B.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E567 - E568
  • [4] Efficiency of Biomarker-Driven Clinical Trial Designs Reply
    Lee, Choong-kun
    Park, Sejung
    Nam, Chung Mo
    Chung, Hyun Cheol
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (12)
  • [5] Biomarker-driven targeted oral treatment strategy for bladder cancer
    Morera, Daley S.
    Jordan, Andre
    Lokeshwar, Vinata B.
    CANCER RESEARCH, 2017, 77
  • [6] Biomarker-driven patient selection for early clinical trials
    Dienstmann, Rodrigo
    Rodon, Jordi
    Tabernero, Josep
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (03) : 305 - 312
  • [7] Development of a biomarker-driven patient selection strategy for AsiDNA treatment
    Jdey, Wael
    O'Brien, Donogh
    Tripelon, Richard
    Rochas, Severine
    Dutreix, Marie
    Bono, Francoise
    CANCER RESEARCH, 2019, 79 (13)
  • [8] STRATIFICATION AND PARTIAL ASCERTAINMENT OF BIOMARKER VALUE IN BIOMARKER-DRIVEN CLINICAL TRIALS
    Simon, Richard
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2014, 24 (05) : 1011 - 1021
  • [9] Novel Clinical Biomarker-Driven Endotyping for Chronic Rhinosinusitis
    Mahesh, Padukudru Anand
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (03): : 930 - 931
  • [10] It's TIME for a biomarker-driven approach to cancer immunotherapy
    Emens, Leisha A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
12345